You are invited to attend a press briefing at the European Association for the Study of Diabetes (EASD) 1999

Tuesday 28 September 1999, 18.30 - 20:00,
Ambassador Room, 1st Floor, Hall 10
Brussels Exhibition and Conference Centre

What is the cost of type 2 diabetes in Europe?
How do different countries compare?
Are current management strategies effective?
Why is insulin resistance important?
Could new approaches save lives and money?

CODE-2* is the first pan-European study to evaluate the economic impact of type 2 diabetes on society.

8 European countries
Over 600 physicians
Over 7000 patients

The press briefing, hosted by members of CODE-2* Advisory Boards, will launch the results of this landmark study and discuss the implications of CODE-2* for the future treatment of type 2 diabetes.

The following CODE-2* experts will speak at the briefing:

• Professor Massimo Massi-Benedetti
  Chair of the International Diabetes Foundation (Europe Region), Italy

• Professor Bengt Jönsson
  Stockholm School of Economics, Sweden

• Dr Andreas Liebl
  Staedtisches Krankenhaus Bogenhausen, Germany

• Dr Robert Young
  Hope Hospital, Salford, UK

To confirm your attendance at the briefing, please contact Barbara Campbell, Susie Hackett or Kate Davies on: Tel: 44-171-404-7151
Email:
[email protected]
[email protected]
[email protected]

SmithKline Beecham Pharmaceuticals -- Advancing Diabetes Care

*Trademark of SmithKline Beecham plc (CODE-2: Costs of Diabetes in Europe -- Type 2)